IP Verse

Amgen vs. Regeneron Pharmaceuticals - CC_24999/2024

The case CC_24999/2024 was filed by the plaintiff Amgen against the defendant Regeneron Pharmaceuticals on 03 May, 2024.

Case Timeline

03 May, 2024
Case Filed
30 Jul, 2024
Counterclaim for Revocation
21 Feb, 2025
Written Procedure
21 Feb, 2025
Rejoinder
21 Feb, 2025
Interim Conference
21 Feb, 2025
Oral Procedure
Today Nov 1, 2025
Decision

Case Details

    Case Number:

    CC_24999/2024

    Patent Number:

    EP3536712

    Filing Date:

    03 May, 2024

    Proceeding Type:

    Counter Claim For Revocation

    Case Phase:

    Case Closed

    Plaintiffs:

    • Amgen
    • Amgen B.V.
    • Amgen Europe B.V.
    • Amgen Gmbh
    • Amgen Inc.
    • Amgen Nv
    • Amgen S.A.S.
    • Amgen S.R.L.

    Plaintiff Representative:

    • Johannes Heselberger

    Defendants:

    • Regeneron Pharmaceuticals
    • Regeneron Pharmaceuticals Inc.

    Defendant Representative:

    • Niels Hoelder
    • Niels Holder

    Judges:

    • Andras Kupecz
    • Berenice Thom
    • Ronny Thomas
    • Xavier Dorland-Galliot
    • Xavier DORLAND-GALLIOT

    Court Division:

    First Instance, Local Division - Dusseldorf

Case Decision

Decision pending - set alert to receive updates

Docket Entries

The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.

Last updated on: Oct 30, 2025
DateTitle

Notify me when new UPC document is filed

May 13, 2025Decisionoutcome
May 13, 2025Decision
Feb 26, 202524999/Oh/Dus Loc/Upc202502250930Am/S04
Feb 26, 202524999/Oh/Dus Loc/Upc202502250930Am/S03
Feb 26, 202524999/Oh/Dus Loc/Upc202502250930Am/S02
Feb 26, 202524999/Oh/Dus Loc/Upc202502250930Am/S01
Feb 21, 2025Written Procedure Closure
Feb 21, 2025Summon Oral Hearing
Feb 21, 2025New Upload Due To Technical Reasons
Feb 21, 2025Interim Procedure Closure
Feb 21, 2025Hearing Dates
Jan 21, 2025Rejoinder To Reply To Defence To Application To Amend
Jan 21, 2025Rejoin Amend Patent Defence
Jan 21, 2025Receipt
Jan 20, 2025Response Re Separation Of EP857 And Value In Litigation
Jan 20, 2025Receipt
Jan 20, 2025250120 Reply To Order On Separation And VALUE Of Action
Dec 16, 2024Reply Amend Patent Defence
Dec 13, 2024Order Set A Date And Summon To Oral Hearing
Dec 13, 2024Hearing Dates
Dec 5, 2024Panel Appointment
Nov 22, 2024Rejoinder To Reply To Application To Amend
Nov 22, 2024Rejoinder
Nov 22, 2024Receipt
Nov 22, 2024Exhibit He 113
Nov 22, 2024Exhibit He 112
Nov 22, 2024Exhibit He 111
Nov 22, 2024Exhibit He 110
Nov 22, 2024Exhibit He 109
Nov 22, 2024Exhibit He 108
Nov 22, 2024Acknowledgement Of Lodging
Oct 31, 2024Reply To Defence To Cfr
Oct 31, 2024Exhibit Bp81
Oct 31, 2024Exhibit Bp80
Oct 31, 2024Exhibit Bp79
Oct 31, 2024Exhibit Bp78
Oct 31, 2024Exhibit Bp77
Oct 31, 2024Exhibit Bp76
Oct 31, 2024Exhibit Bp75A
Oct 31, 2024Exhibit Bp75
Oct 31, 2024Acknowledgement Of Lodging
Oct 23, 2024He 113 Panteghini 1993
Oct 23, 2024He 112 Angelin And Rudling
Oct 23, 2024He 111 Tsimikas
Oct 23, 2024He 110 Ghiselli 1992
Oct 23, 2024He 109 Analysis Of Lipid Related Outcomes Measured In Clinical Trials
Oct 23, 2024He 108 Second Declaration Of Prof Di Angelantonio (Signed)
Oct 23, 2024.10.23 Rejoinder To The Reply To The Defence To The Counterclaim Signed
Sep 23, 2024Receipt
Sep 23, 2024Infringement Rejoinder And Validity Reply
Sep 23, 2024Exhibit Bp81
Sep 23, 2024Exhibit Bp80
Sep 23, 2024Exhibit Bp79
Sep 23, 2024Exhibit Bp78
Sep 23, 2024Exhibit Bp77
Sep 23, 2024Exhibit Bp76
Sep 23, 2024Exhibit Bp75
Sep 23, 2024Acknowledgement Of Lodging
Aug 1, 2024Formal Checks Notification Of Positive Outcome
Aug 1, 2024Acknowledgement Of Lodging
Jul 31, 2024Response To Sod And Defence To Counterclaim And Application To Amend
Jul 31, 2024Ar5B
Jul 31, 2024Ar5A
Jul 31, 2024Ar5
Jul 31, 2024Ar4B
Jul 31, 2024Ar4A
Jul 31, 2024Ar4
Jul 31, 2024Ar3B
Jul 31, 2024Ar3A
Jul 31, 2024Ar3
Jul 31, 2024Ar2B
Jul 31, 2024Ar2A
Jul 31, 2024Ar2
Jul 31, 2024Ar1B
Jul 31, 2024Ar1A
Jul 31, 2024Ar1
Jul 30, 2024He 99
Jul 30, 2024He 98
Jul 30, 2024He 97
Jul 30, 2024He 96
Jul 30, 2024He 95
Jul 30, 2024He 94
Jul 30, 2024He 93
Jul 30, 2024He 92
Jul 30, 2024He 91
Jul 30, 2024He 90
Jul 30, 2024He 89
Jul 30, 2024He 88
Jul 30, 2024He 87
Jul 30, 2024He 86
Jul 30, 2024He 85
Jul 30, 2024He 84
Jul 30, 2024He 83
Jul 30, 2024He 82
Jul 30, 2024He 81
Jul 30, 2024He 80
Jul 30, 2024He 79
Jul 30, 2024He 78
Jul 30, 2024He 77
Jul 30, 2024He 76
Jul 30, 2024He 75
Jul 30, 2024He 74
Jul 30, 2024He 73
Jul 30, 2024He 72
Jul 30, 2024He 71
Jul 30, 2024He 70
Jul 30, 2024He 69
Jul 30, 2024He 68
Jul 30, 2024He 67
Jul 30, 2024He 66
Jul 30, 2024He 65
Jul 30, 2024He 64
Jul 30, 2024He 63
Jul 30, 2024He 62
Jul 30, 2024He 61
Jul 30, 2024He 60
Jul 30, 2024He 59A
Jul 30, 2024He 59
Jul 30, 2024He 58A
Jul 30, 2024He 58
Jul 30, 2024He 57A
Jul 30, 2024He 57
Jul 30, 2024He 56
Jul 30, 2024He 55A
Jul 30, 2024He 55
Jul 30, 2024He 54
Jul 30, 2024He 53
Jul 30, 2024He 52
Jul 30, 2024He 51A
Jul 30, 2024He 51
Jul 30, 2024He 50A
Jul 30, 2024He 50
Jul 30, 2024He 49
Jul 30, 2024He 48
Jul 30, 2024He 47A
Jul 30, 2024He 47
Jul 30, 2024He 46A
Jul 30, 2024He 46
Jul 30, 2024He 45A
Jul 30, 2024He 45
Jul 30, 2024He 44A
Jul 30, 2024He 44
Jul 30, 2024He 43A
Jul 30, 2024He 43
Jul 30, 2024He 42A
Jul 30, 2024He 42
Jul 30, 2024He 41
Jul 30, 2024He 40B
Jul 30, 2024He 40A
Jul 30, 2024He 40
Jul 30, 2024He 39
Jul 30, 2024He 38A
Jul 30, 2024He 38
Jul 30, 2024He 37
Jul 30, 2024He 36
Jul 30, 2024He 35
Jul 30, 2024He 34
Jul 30, 2024He 33
Jul 30, 2024He 32
Jul 30, 2024He 31
Jul 30, 2024He 30
Jul 30, 2024He 29
Jul 30, 2024He 28
Jul 30, 2024He 27
Jul 30, 2024He 26A
Jul 30, 2024He 26
Jul 30, 2024He 25A
Jul 30, 2024He 25
Jul 30, 2024He 24
Jul 30, 2024He 23
Jul 30, 2024He 22
Jul 30, 2024He 21
Jul 30, 2024He 20
Jul 30, 2024He 19
Jul 30, 2024He 18
Jul 30, 2024He 17
Jul 30, 2024He 16
Jul 30, 2024He 15
Jul 30, 2024He 14
Jul 30, 2024He 13
Jul 30, 2024He 12
Jul 30, 2024He 11
Jul 30, 2024He 103
Jul 30, 2024He 102
Jul 30, 2024He 101
Jul 30, 2024He 100
Jul 30, 2024He 10
Jul 30, 2024He 09
Jul 30, 2024He 08
Jul 30, 2024He 07
Jul 30, 2024He 06
Jul 30, 2024He 05
Jul 30, 2024He 04
Jul 30, 2024He 03
Jul 30, 2024He 02
Jul 30, 2024He 01
Jul 30, 2024Formal Checks Notification Of Positive Outcome
Jul 30, 2024Ar5B
Jul 30, 2024Ar5A
Jul 30, 2024Ar5
Jul 30, 2024Ar4B
Jul 30, 2024Ar4A
Jul 30, 2024Ar4
Jul 30, 2024Ar3B
Jul 30, 2024Ar3A
Jul 30, 2024Ar3
Jul 30, 2024Ar2B
Jul 30, 2024Ar2A
Jul 30, 2024Ar2
Jul 30, 2024Ar1B
Jul 30, 2024Ar1A
Jul 30, 2024Ar1
Jul 30, 2024Acknowledgement Of Lodging
Jul 30, 2024240722 Response To Sod And Defense To Counterclaim Sgn
Jul 25, 2024Notification Of Service
Jul 25, 2024Acknowledgement Of Access To Case
May 16, 2024Epouploaddocumentsworkflow
May 15, 2024Document From Epo
May 7, 2024Panel Appointment
May 7, 2024Formal Checks Notification Of Positive Outcome
May 7, 2024Epo Request For Case Pending
May 7, 2024Acknowledgement Of Lodging
May 3, 2024Statement Of Defense
May 3, 2024Payment Confirmation
May 3, 2024Exhibit Bp73
May 3, 2024Exhibit Bp72
May 3, 2024Exhibit Bp71
May 3, 2024Exhibit Bp70A
May 3, 2024Exhibit Bp70
May 3, 2024Exhibit Bp69A
May 3, 2024Exhibit Bp69
May 3, 2024Exhibit Bp68A
May 3, 2024Exhibit Bp68
May 3, 2024Exhibit Bp67A
May 3, 2024Exhibit Bp67
May 3, 2024Exhibit Bp66A
May 3, 2024Exhibit Bp66
May 3, 2024Exhibit Bp65
May 3, 2024Exhibit Bp64A
May 3, 2024Exhibit Bp64
May 3, 2024Exhibit Bp63A
May 3, 2024Exhibit Bp63
May 3, 2024Exhibit Bp62
May 3, 2024Exhibit Bp61
May 3, 2024Exhibit Bp60A
May 3, 2024Exhibit Bp60
May 3, 2024Exhibit Bp59
May 3, 2024Exhibit Bp58
May 3, 2024Exhibit Bp57
May 3, 2024Exhibit Bp56 Part 2
May 3, 2024Exhibit Bp56 Part 1
May 3, 2024Exhibit Bp56A
May 3, 2024Exhibit Bp55
May 3, 2024Exhibit Bp54
May 3, 2024Exhibit Bp53A
May 3, 2024Exhibit Bp53
May 3, 2024Exhibit Bp52A
May 3, 2024Exhibit Bp52
May 3, 2024Exhibit Bp51A
May 3, 2024Exhibit Bp51
May 3, 2024Exhibit Bp50A
May 3, 2024Exhibit Bp50
May 3, 2024Exhibit Bp49A
May 3, 2024Exhibit Bp49
May 3, 2024Exhibit Bp48A
May 3, 2024Exhibit Bp48
May 3, 2024Exhibit Bp47A
May 3, 2024Exhibit Bp47
May 3, 2024Exhibit Bp46A
May 3, 2024Exhibit Bp46
May 3, 2024Exhibit Bp45
May 3, 2024Exhibit Bp44
May 3, 2024Exhibit Bp43
May 3, 2024Exhibit Bp42
May 3, 2024Exhibit Bp41
May 3, 2024Exhibit Bp40
May 3, 2024Exhibit Bp39
May 3, 2024Exhibit Bp38
May 3, 2024Exhibit Bp37
May 3, 2024Exhibit Bp36
May 3, 2024Exhibit Bp35
May 3, 2024Exhibit Bp34A
May 3, 2024Exhibit Bp34
May 3, 2024Exhibit Bp33A
May 3, 2024Exhibit Bp33
May 3, 2024Exhibit Bp32
May 3, 2024Exhibit Bp31
May 3, 2024Exhibit Bp30
May 3, 2024Exhibit Bp29
May 3, 2024Exhibit Bp28
May 3, 2024Exhibit Bp27
May 3, 2024Exhibit Bp26
May 3, 2024Exhibit Bp25
May 3, 2024Exhibit Bp24
May 3, 2024Exhibit Bp23
May 3, 2024Exhibit Bp22
May 3, 2024Exhibit Bp21
May 3, 2024Exhibit Bp20
May 3, 2024Exhibit Bp19
May 3, 2024Exhibit Bp18
May 3, 2024Exhibit Bp17
May 3, 2024Exhibit Bp16
May 3, 2024Exhibit Bp15
May 3, 2024Exhibit Bp14
May 3, 2024Exhibit Bp13
May 3, 2024Exhibit Bp12
May 3, 2024Exhibit Bp11
May 3, 2024Exhibit Bp10
May 3, 2024Exhibit Bp09
May 3, 2024Exhibit Bp08
May 3, 2024Exhibit Bp07
May 3, 2024Exhibit Bp06 Part 4
May 3, 2024Exhibit Bp06 Part 3
May 3, 2024Exhibit Bp06 Part 2
May 3, 2024Exhibit Bp06 Part 1
May 3, 2024Exhibit Bp05

More cases involving EP3536712B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APL_32715/2025Jul 14, 2025Regeneron Pharmaceuticals, Sanofi BiotechnologiesAmgen, Amgen Europe
UPC_COA_641/2025Jul 14, 2025Sanofi BiotechnologyAmgen
APL_32765/2025Jul 11, 2025Amgen, Amgen EuropeRegeneron Pharmaceuticals

More cases involving Amgen

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_35200/2025Aug 21, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -
APP_35086/2025Aug 20, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -
APP_35087/2025Aug 20, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -

More cases involving Regeneron Pharmaceuticals

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_34318/2025Aug 5, 2025Regeneron Pharmaceuticals -
ORD_34329/2025Aug 5, 2025AmgenRegeneron Pharmaceuticals
APP_33251/2025Jul 21, 2025Regeneron Pharmaceuticals -